Hostname: page-component-848d4c4894-5nwft Total loading time: 0 Render date: 2024-05-07T19:21:07.280Z Has data issue: false hasContentIssue false

Do Case Series have a Role in an Evidence-Based Medical Culture?

Published online by Cambridge University Press:  02 December 2014

Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Copyright
Copyright © The Canadian Journal of Neurological 2001

References

1. Heller, GL, DeJong, RN. Treatment of the Guillain-Barré syndrome.Use of corticotropin and glucocorticoids. Arch Neurol 1963;8:179193.CrossRefGoogle Scholar
2. Goodall, JAD, Kosmidis, JC, geddes, AM. Effect of corticosteroidson course of Guillain-Barré syndrome (letter). Lancet 1974;1:524.CrossRefGoogle Scholar
3. Hughes, RC, Van der Meche, FG. Corticosteroids for treatingGuillain-Barré syndrome. Cochrane Database of Systematic Reviews 2001;2.Google Scholar
4. Dyck, PJB, Norell, JE, Dyck, PJ. Methylprednisolone may improveLumbosacral Radiculoplexus Neuropathy. Can J Neurol Sci 2001;28:224227.Google Scholar
5. Dyck, PJB, Norell, JE,Dyck, PJ. Non-diabetic lumbosacral radiculo-plexus neuropathy. Natural history, outcome and comparison with the diabetic variety. Brain 2001;124(Pt 6):11971207.Google Scholar
6. Dyck, PJ, O’Brien, PC, Oviatt, KF, et al. Prednisone improves chronicinflammatory demyelinating polyneuropathy more than no treatment. Ann Neurol 1982;11:136141.Google Scholar
7. Barohn, RJ, Kissel, JT, Warmolts, JR, Mendell, JR. Chronicinflammatory demyelinating polyneuropathy. Arch Neurol 1989;46:878884.Google Scholar
8. Said, G, Elgrably, F, Lacroix, C, et al. Painful Proximal DiabeticNeuropathy: Inflammatory Nerve Lesions and Spontaneous Favorable Outcome. Ann Neurol 1997;41:762770.CrossRefGoogle Scholar
9. Thomas, P. Diabetic neuropathy: models, mechanisms and mayhem. Can J Neurol Sci 1992;19:17.Google Scholar